<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04550650</url>
  </required_header>
  <id_info>
    <org_study_id>IKEB2020/08</org_study_id>
    <nct_id>NCT04550650</nct_id>
  </id_info>
  <brief_title>Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients</brief_title>
  <official_title>Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Somogy Megyei Kaposi Mór Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Somogy Megyei Kaposi Mór Teaching Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Different therapies can improve clinical and motor symptoms of multiple sclerosis (MS)&#xD;
      similarly, but studies comparing the effects of different exercise therapies on clinical and&#xD;
      motor outcomes are scant. We compared the effects of exergaming (EXE), balance (BAL), cycling&#xD;
      (CYC), proprioceptive neuromuscular facilitation (PNF), and a standard care wait-listed&#xD;
      control group (CON) on clinical and motor symptoms and quality of life (QoL) in people with&#xD;
      MS (PwMS).&#xD;
&#xD;
      Methods: PwMS (n = 68, 90% female; age, 47.0 yr; Expanded Disability Status Scale score 5-6)&#xD;
      were randomized into five groups. Before and after the interventions (five times a week for 5&#xD;
      wk), PwMS were tested for MS-related clinical and motor symptoms (Multiple Sclerosis Impact&#xD;
      Scale-29 (MSIS-29), primary outcome), QoL (EuroQol Five Dimensions Questionnaire), symptoms&#xD;
      of depression, gait and balance ability (Tinetti Assessment Tool), static and dynamic balance&#xD;
      and fall risk (Berg Balance Scale), walking capacity (6-min walk test), and standing&#xD;
      posturography on a force platform.&#xD;
&#xD;
      Patients were followed up for 2 years after 5 weeks of intensive care. Tests are performed&#xD;
      every six months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 6, 2018</start_date>
  <completion_date type="Actual">September 1, 2020</completion_date>
  <primary_completion_date type="Actual">April 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postural instability</measure>
    <time_frame>2 years</time_frame>
    <description>Body sway (mm) (Posturography test)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EQ-5D quality of life</measure>
    <time_frame>2 years</time_frame>
    <description>EQ-5D (EQ-5D was first introduced in 1990 by the EuroQol Group, The EQ-5D questionnaire is made up for two components; health state description and evaluation)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>balance test</measure>
    <time_frame>2 years</time_frame>
    <description>Berg Balance test (The Berg Balance Scale (BBS) was developed to measure balance among older people with impairment in balance function by assessing the performance of functional tasks, 41-56 = low fall risk, 21-40 = medium fall risk, 0 -20 = high fall risk )</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mobility test</measure>
    <time_frame>2 years</time_frame>
    <description>Six minutes walk test (6MWT) (m) (The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>depression scale</measure>
    <time_frame>2 years</time_frame>
    <description>Beck Depression scale (The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression, 0-13: minimal depression, 14-19: mild depression, 20-28: moderate depression, 29-63: severe depression)</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Multiple Sclerosis, Chronic Progressive</condition>
  <condition>Multiple Sclerosis, Primary Progressive</condition>
  <arm_group>
    <arm_group_label>Controll</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training grp</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neurorehabilitation 2 years long intervention, administered daily, targeted postural instability, balance and mobility using at-limit intensity sensorimotor and visuomotor agility training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PNF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 years long, You have only treated patients with the PNF technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spinning group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients developed endurance for 2 years. They worked using a spinning bike.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Balance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neurorehabilitation 2 years long intervention, administered daily, targeted postural instability, balance</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training groupe</intervention_name>
    <description>Using virtual training</description>
    <arm_group_label>Training grp</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PNF</intervention_name>
    <description>PNF technique was used</description>
    <arm_group_label>PNF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spinning grp</intervention_name>
    <description>They only worked with spinning bikes.</description>
    <arm_group_label>Spinning group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Balance</intervention_name>
    <description>Balance development was done</description>
    <arm_group_label>Balance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Multiple Sclerosis&#xD;
&#xD;
          -  instability problem&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        • Severe heart problems, severe demeanor, alcoholism, drug problems&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Somogy Megyei Kaposi Mór Oktató Kórház</name>
      <address>
        <city>Kaposvár</city>
        <state>Somogy</state>
        <zip>7400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/?term=MS+rehabilitation</url>
    <description>Related Info</description>
  </link>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 10, 2020</study_first_submitted>
  <study_first_submitted_qc>September 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>July 5, 2021</last_update_submitted>
  <last_update_submitted_qc>July 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Somogy Megyei Kaposi Mór Teaching Hospital</investigator_affiliation>
    <investigator_full_name>Tollár József</investigator_full_name>
    <investigator_title>Dr. József Tollár, Head of Neurorehabilitation ,7400 Kaposvár, Tallián Gy. u 20-32</investigator_title>
  </responsible_party>
  <keyword>multiple sclerosis</keyword>
  <keyword>posture</keyword>
  <keyword>neurorehabilitation</keyword>
  <keyword>balance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis, Chronic Progressive</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

